Abbott India delays plans of sale/ transfer of proprietary pharma division

04 Jun 2013 Evaluate

Abbott India has decided to put on back burner the plans for sale and transfer of or other appropriate restructuring of the proprietary pharmaceuticals division (PPD) of the company. The company’s board of directors at their meeting held on June 3, 2013, decided the same. In the year ended December 31, 2012, the PPD business accounted for sales of Rs 76.22 crore which constituted of 4.73% of the net sales of Rs 1613.09 crore of the company.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services. In 1888 a young Chicago physician, Dr Wallace Calvin Abbott founded Abbott Laboratories.

Abbott India Share Price

27829.85 131.70 (0.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×